ArticleInternational journal of molecular sciences2023

Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab.

Florian Rissel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.